SARS-associated coronavirus transmission, United States

被引:37
作者
Isakbaeva, ET
Khetsuriani, N
Beard, RS
Peck, A
Erdman, D
Monroe, SS
Tong, SX
Ksiazek, TG
Lowther, S
Pandya-Smith, I
Anderson, LJ
Lingappa, J
Widdowson, MA
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] McKing Consulting, Atlanta, GA USA
关键词
D O I
10.3201/eid1002.030734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To better assess the risk for transmission of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV), we obtained serial specimens and clinical and exposure data from seven confirmed U.S. SARS patients and their 10 household contacts. SARS-CoV was detected in a day-14 sputum specimen from one case-patient and in five stool specimens from two case-patients. In one case-patient, SARS-CoV persisted in stool for at least 26 days after symptom onset. The highest amounts of virus were in the day-14 sputum sample and a day-14 stool sample. Residual respiratory symptoms were still present in recovered SARS case-patients 2 months after illness onset. Possible transmission of SARS-CoV occurred in one household contact, but this person had also traveled to a SARS-affected area. The data suggest that SARS-CoV is not always transmitted efficiently. Routine collection and testing of stool and sputum specimens of probable SARS case-patients may help the early detection of SARS-CoV infection.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 21 条
  • [1] Avendano M, 2003, CAN MED ASSOC J, V168, P1649
  • [2] Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
    Booth, CM
    Matukas, LM
    Tomlinson, GA
    Rachlis, AR
    Rose, DB
    Dwosh, HA
    Walmsley, SL
    Mazzulli, T
    Avendano, M
    Derkach, P
    Ephtimios, IE
    Kitai, I
    Mederski, BD
    Shadowitz, SB
    Gold, WL
    Hawryluck, LA
    Rea, E
    Chenkin, JS
    Cescon, DW
    Poutanen, SM
    Detsky, AS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21): : 2801 - 2809
  • [3] *CDCP, 2003, INT LAB BIOS GUID HA
  • [4] *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241
  • [5] *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P391
  • [6] *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P433
  • [7] Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405
  • [8] *DEP HLTH GOV HONG, 2003, OUTBR SEV AC RESP SY
  • [9] Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
    Donnelly, CA
    Ghani, AC
    Leung, GM
    Hedley, AJ
    Fraser, C
    Riley, S
    Abu-Raddad, LJ
    Ho, LM
    Thach, TQ
    Chau, P
    Chan, KP
    Lam, TH
    Tse, LY
    Tsang, T
    Liu, SH
    Kong, JHB
    Lau, EMC
    Ferguson, NM
    Anderson, RM
    [J]. LANCET, 2003, 361 (9371) : 1761 - 1766
  • [10] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976